Your browser doesn't support javascript.
loading
Exposure-Response of Veliparib to Inform Phase II Trial Design in Refractory or Relapsed Patients with Hematological Malignancies.
Mehrotra, Shailly; Gopalakrishnan, Mathangi; Gobburu, Jogarao; Ji, Jiuping; Greer, Jacqueline M; Piekarz, Richard; Karp, Judith E; Pratz, Keith W; Rudek, Michelle A.
Afiliación
  • Mehrotra S; Center for Translational Medicine, University of Maryland, Baltimore, Maryland.
  • Gopalakrishnan M; Center for Translational Medicine, University of Maryland, Baltimore, Maryland. mrudek2@jhmi.edu mgopalakrishnan@rx.umaryland.edu.
  • Gobburu J; Center for Translational Medicine, University of Maryland, Baltimore, Maryland.
  • Ji J; Frederick National Laboratory for Cancer Research, Frederick, Maryland.
  • Greer JM; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland.
  • Piekarz R; Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.
  • Karp JE; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland.
  • Pratz KW; Department of Oncology, Johns Hopkins University, Baltimore, Maryland.
  • Rudek MA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland.
Clin Cancer Res ; 23(21): 6421-6429, 2017 Nov 01.
Article en En | MEDLINE | ID: mdl-28751440
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Bencimidazoles / Neoplasias Hematológicas / Inhibidores de Poli(ADP-Ribosa) Polimerasas Tipo de estudio: Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Bencimidazoles / Neoplasias Hematológicas / Inhibidores de Poli(ADP-Ribosa) Polimerasas Tipo de estudio: Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article